ISPOR PUBLISHES NEW TASK FORCE REPORT ON MULTIPLE CRITERIA DECISION ANALYSIS

Published Jan 26, 2016

First of Two Reports Published in Value in Health

Princeton, NJ—January 26, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force,” in the January/February 2016 issue of Value in Health (Volume 19, Issue 1). Health care decisions are complex and can require the assessment of multiple, often conflicting, objectives. As a result, decision makers—whether they are individuals or committees—often have difficulty processing and systematically evaluating relevant information that could inform those decisions. A set of techniques known under the collective heading multiple criteria decision analysis (MCDA), can be useful to evaluate multiple variables (i.e., criteria) and improve the quality of decision making. MCDA has been widely used in other sectors and is now being increasingly applied in health care. However, while there are many MCDA methods available, little guidance exists for how to choose the right technique for a particular problem. To fill this knowledge gap, ISPOR established its Multi-Criteria Decision Analysis in Health Care Decision Making Emerging Good Practices Task Force in 2014. This first MCDA Task Force Report provides readers with an introduction that: 1) defines MCDA, 2) offers examples of its use in different kinds of health care decision making, 3) provides an overview of the principal methods of MCDA, and 4) describes the key steps involved. A second Task Force Report is in development and is scheduled for publication in the March/April 2016 issue of Value in Health. Report 2 will build on the first report by providing recommendations on Emerging Good Practices for conducting MCDA.

###

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.

ISPOR Champions Research Transparency With Launch of Open Science Badges

Aug 4, 2025

ISPOR introduced an initiative to recognize transparency in research for papers published in Value in Health, its preeminent HEOR journal.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×